R1 RCM Inc

R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Murray, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

R1 RCM Inc (RCM) posts strong Q4 results, eyes Cloudmed growth

R1 RCM Inc (RCM) delivered robust financial performance in Q4 2022, focusing on operational excellence, technology investments, and customer engagement. Challenges include integration efforts and seasonality affecting incentive fees. The company is poised for growth with opportunities in Cloudmed expansion and AI utilization.

R1 RCM Inc (RCM) reports strong Q1 results and growth opportunities

R1 RCM Inc (RCM) delivered strong Q1 results, with a focus on operational improvements, robust Cloudmed growth, and positive financial outlook for 2023.
The company showcased resilience in stable patient self-pay trends, improving payer reimbursement timelines, and strategic capacity for onboarding new NPR, positioning itself for continued success.
Challenges include industry financial pressures, sustaining growth in legacy business, and managing operational costs effectively, requiring strategic adaptation and continuous innovation.
Opportunities lie in pipeline visibility for deals, sequential EBITDA growth, integration of Cloudmed capabilities, and strategic onboarding plans, offering avenues for expansion and profitability.

R1 RCM Inc reports robust Q2 earnings, eyes growth opportunities

R1 RCM Inc's Q2 performance was strong, with a focus on technology and operational enhancements. Challenges include revenue adjustments and workforce implications of automation. Opportunities lie in improved payer dynamics and growth through physician market focus and cross-selling.

R1 RCM Inc reports robust Q3 performance and eyes growth

R1 RCM Inc's Q3 earnings call highlighted strong financial performance, strategic priorities, and challenges in pediatric contracts and integration issues.
The company's focus on revenue optimization, leveraging technology, and partnership with Microsoft positions it well for growth opportunities within the customer base and offshoring initiatives.
While facing challenges in deal timings and debt repayment, R1 RCM Inc's emphasis on operational metrics, customer relationships, and workforce management presents avenues for continued success and industry leadership.

R1 RCM Inc reports robust Q4 earnings, eyes growth opportunities

R1 RCM Inc's Q4 2023 earnings call highlighted strong financial performance, strategic objectives for 2023, and a confident outlook for sustainable growth and shareholder value creation.
The company's emphasis on customer-centricity, AI integration, and operational efficiency underscores its strengths in revenue growth and market positioning.
While facing challenges in credit allowances and customer health, R1 RCM Inc aims to leverage opportunities in reduced costs, synergies from acquisitions, and strategic sales to drive future growth.

R1 RCM reports resilient Q1 performance post-cyberattack, eyes growth

R1 RCM showcased resilience in Q1 2024 despite the Change Healthcare cyberattack, focusing on growth strategies, operational excellence, and technology innovation.
The company faces challenges from the cyberattack impact on KPIs and vendor changes but sees opportunities in the managed care environment and customer engagement.
Overall, R1 RCM remains optimistic about transforming the industry through technology and expertise, with a strong market demand for its solutions.

R1 RCM Inc reports robust Q2 earnings amidst cyberattack challenges

R1 RCM Inc's Q2 2024 earnings call showcased strong financial performance, operational resilience in the face of cyberattacks, and a strategic focus on growth initiatives. The company faces challenges related to pending transactions and cyberattack impacts but sees opportunities in expanding its platform and leveraging technology for growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

R1 RCM Inc. (RCM) CEO Joe Flanagan on Q4 2020 Results - Earnings Call Transcript

R1 RCM Inc. (RCM) delivered earnings and revenue surprises of 0.00% and 3.71%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

R1 RCM Inc. (RCM) Q4 Earnings Meet Estimates

CHICAGO, Feb. 18, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months and year ended December 31, 2020.

R1 RCM Reports Fourth Quarter and Full Year 2020 Results

Customers rank R1 as Best in KLAS® in prestigious annual survey

R1 RCM Ranked #1 by KLAS for Ambulatory Revenue Cycle Management Services

CHICAGO, Feb. 01, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it expects to release financial results for the three months and full year ended December 31, 2020 before market open on Thursday, February 18, 2021.

R1 RCM to Release Fourth Quarter 2020 Results on February 18

SWKH vs. RCM: Which Stock Is the Better Value Option?

New York, New York--(Newsfile Corp. - January 21, 2021) - Levi & Korsinsky announces it has commenced an investigation of R1 RCM Inc. (NASDAQ: RCM) concerning possible breaches of fiduciary duty. To obtain additional information, go to:https://www.zlk.com/compensation2/r1-rcm-inc-information-request-formor contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of R1 RCM Inc. - RCM

New York, New York--(Newsfile Corp. - January 18, 2021) - Levi & Korsinsky announces it has commenced an investigation of R1 RCM Inc. (NASDAQ: RCM) concerning possible breaches of fiduciary duty. To obtain additional information, go to:https://www.zlk.com/compensation2/r1-rcm-inc-information-request-formor contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of R1 RCM Inc. - RCM

NEW YORK, Jan. 18, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of R1 RCM Inc. (NASDAQ: RCM). If you are a...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating R1 RCM Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

AMN Healthcare Services

Masimo

Royal Philips

The booming digital health space has been witnessing significant M&A activities amid the pandemic.

Digital Health M&As Gain Precedence in the New Normal

R1 RCM (RCM) has moved higher as of late, but there could definitely be trouble on the horizon for this company.

R1 RCM (RCM) is Overbought: Is A Drop Coming?

CHICAGO, Dec. 30, 2020 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of revenue cycle management services to healthcare providers, today announced its management team will present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 10:50 am ET.

R1 RCM to Present at the 39th Annual J.P. Morgan Healthcare Conference

R1 RCM, Inc. (RCM) CEO Joe Flanagan on Q3 2020 Results - Earnings Call Transcript

CHICAGO, Nov. 03, 2020 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results for the three months ended September 30, 2020.

R1 RCM Reports Third Quarter 2020 Results

R1 (RCM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Is a Surprise Coming for R1 (RCM) This Earnings Season?

CHICAGO, Oct. 30, 2020 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, announced it has completed the sale of its emergency medical services (EMS) business, including EMS Revenue Cycle Management and Electronic Patient Care Reporting, to Sarnova Holdings, Inc., a leading specialty distributor of healthcare products in the EMS and acute care markets and a subsidiary of Patricia Industries.

R1 Completes Sale of its Emergency Medical Services Business to Sarnova Holdings, Inc.

BRENTWOOD, Tenn. and CHICAGO, Oct. 28, 2020 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leader in technology-enabled revenue cycle management (RCM) services to healthcare providers, and LifePoint Health, a national network of hospitals, post-acute services, outpatient centers and providers in more than 80 locations, have entered into a new revenue cycle management agreement that will make R1 the exclusive revenue cycle management partner for more than one-third of LifePoint hospitals. The comprehensive partnership is designed to enhance patient experience and streamline operations to meet the evolving needs of the health system now and into the future for the communities LifePoint serves.

LifePoint Health and R1 RCM Announce Partnership to Deliver Revenue Cycle Excellence and Enhance Patient Experience

CHICAGO, Oct. 20, 2020 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it expects to release financial results for the three months ended September 30, 2020 before market open on Tuesday, November 3, 2020.

R1 RCM to Release Third Quarter 2020 Results on November 3

Allied Motion Technologies

Sciplay Corp

They may be off the radar, but each name is packing a punch that deserves a closer look from investors.

3 Top Small-Cap Stocks to Buy in October

EMpower Emergency Physicians and Integrated Care Physicians select R1 revenue cycle services to drive improvements in patient experience and financial operations EMpower Emergency Physicians and Integrated Care Physicians select R1 revenue cycle services to drive improvements in patient experience and financial operations

R1 Increases Footprint in Hospital-Based Physician Market with Addition of Prominent Emergency Physician Groups

R1 RCM Is A Rare Health Tech Winner

Mr. Cooper Group Inc

Express

iShares Core S&P Small Cap ETF

Pennsylvania Real Estate Investment Trust

Two additions to the S&P SmallCap 600 are rocketing higher, while the two cuts are falling hard.

2 Winners and 2 Losers in Today's S&P Index Changes

R1 RCM's (RCM) CEO Joe Flanagan on Q2 2020 Results - Earnings Call Transcript

CHICAGO, Aug.  03, 2020  (GLOBE NEWSWIRE) -- Rush University System for Health (RUSH) and R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced the launch of a joint Innovation Lab to deliver solutions to improve the quality of care for patients on a national scale.

RUSH and R1 Launch Innovation Lab to Drive Industry-Leading Quality and Patient Experience

CHICAGO, Aug.  03, 2020  (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced it has completed the acquisition of the Cerner RevWorks services business and commercial, non-federal client relationships.

News for R1 RCM Inc Stock (RCM)